• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Dr. Reddy's Laboratories Limited — Updates, 13-06-2026: Press Release

    13-06-2026 | 01:03 pm

    Dr. Reddy's launched Bosutinib Tablets 400mg, a first-to-market generic of Bosulif®, in the US. This expands its oncology portfolio and is eligible for 180-day exclusivity. Bosulif® had US sales of approximately $253.8 million, indicating significant market potential.

    No comments yet. Be the first to comment!

    All announcements from Dr. Reddy's Laboratories Limited